Here are three things to know about the discontinued discussions.
1. Since early April, St. Francis had been in “exclusive discussions” with a subsidiary of Franklin, Tenn.-based Community Health Systems. Prior to that, St. Francis announced it was in exclusive discussions with Atlanta-based Piedmont Healthcare. The talks with Piedmont ended by early March, the same month that St. Francis President and CEO Robert P. Granger resigned.
2. On Tuesday, St. Francis declined to answer any questions from the Ledger-Enquirer about the potential deal with CHS or any possible new suitors. However, multiple sources have said St. Francis is now talking to Brentwood, Tenn.-based LifePoint Health about a possible sale, according to the report. LifePoint had not confirmed that as of early this week.
3. Before saying all previous talks were off, St. Francis issued the following statement late Tuesday afternoon from Board of Trustees Chairman Richard “Bo” Bradley: “St. Francis continues to have strong volumes and revenues. The board, physicians and associates continue to be focused on delivering quality care to patients. All groups are dedicated to ensuring the hospital is operating to provide quality healthcare and extensive services to the community. The board appreciates the continued support of the community and looks forward to the future.”
More articles on hospital transactions and valuation issues:
Mayo Care Network inks contract with Singapore health system
LifePoint seeks to expand footprint into South Carolina
NYU Langone pursuing merger with Lutheran Medical Center: 6 things to know
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
